AMERITAS LIFE INSURANCE CORP. – Trademark Portfolio
Entity Type: 03
AMERITAS LIFE INSURANCE CORP. holds 63 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 61 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 8 trademarks are registered and 3 are pending. Notable registered marks include FOCUS, AMERITAS, and GAMEPLAN BY AMERITAS. The owner is based in LINCOLN, NE.
1345 N ST.
LINCOLN, NE 68508
Showing of trademarks Trademarks
Trademark Classifications
AMERITAS LIFE INSURANCE CORP.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does AMERITAS LIFE INSURANCE CORP. have?
AMERITAS LIFE INSURANCE CORP. has 63 U.S. trademarks filed with the USPTO. Of these, 8 registered, 3 pending, 15 abandoned, 37 cancelled.
What trademark classes does AMERITAS LIFE INSURANCE CORP. file in?
AMERITAS LIFE INSURANCE CORP. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are AMERITAS LIFE INSURANCE CORP.'s most well-known trademarks?
AMERITAS LIFE INSURANCE CORP.'s registered trademark portfolio includes well-known marks such as FOCUS, AMERITAS, and GAMEPLAN BY AMERITAS. These are among 8 currently registered trademarks in the portfolio.
What is AMERITAS LIFE INSURANCE CORP.'s trademark registration success rate?
AMERITAS LIFE INSURANCE CORP. has a 13% trademark registration rate, with 8 out of 60 resolved applications resulting in successful registration. Currently, 3 applications are pending review.